Blanca Abrio-Felipe
IS Carlos III
Madrid, MD, Spain
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment.
Journal: Signal transduction and targeted therapy
Published: January 28, 2020
The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness.
Journal: Cancers
Published: November 28, 2019
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
Journal: Molecular cancer
Published: September 14, 2019
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 20, 2019
c-MYB- and PGC1a-dependent metabolic switch induced by MYBBP1A loss in renal cancer.
Journal: Molecular oncology
Published: March 11, 2019
Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.
Journal: Cancers
Published: January 09, 2019
Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.
Journal: Oncotarget
Published: May 13, 2017
Genetic modification of hypoxia signaling in animal models and its effect on cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 24, 2014
Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 05, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026